Cortene Inc.

vials
Cortene Inc. is dedicated to developing therapeutics aimed at treating a broad range of disorders related to the stress response.  Our initial indication is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), for which we are developing CT38.